A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults

Conditions:   Shingles;   Herpes Zoster Infection;   Human Interventions:   Biological: Candidate 1: PF-07915234: VZV modRNA Powder for Suspension for Injection;   Biological: Candidate 1: PF-07915234: VZV modRNA Suspension for Injection;   Biological: Candidate 2: PF-07921188: VZV modRNA Suspension for Injection;   Biological: Candidate 3: PF-07921186: VZV modRNA Su spension for Injection;   Biological: Shingrix;   Biological: Selected Vaccine Candidate group (Dose level, Schedule);   Biological: Shingrix - SSB Sponsor:   Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials